Sepsis is change and flows ever onwards

References

• Liu L, Johnson HL, Cousens S, et al. Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000. Lancet. 2012;379:2151–2161.
   PubMed Web of Science ®Google Scholar
• Workman JK, Ames SG, Reeder RW, et al. Treatment of pediatric septic shock with the surviving sepsis campaign guidelines and PICU patient outcomes. Pediatr Crit Care Med. 2016;17:e451–e458.
   Google Scholar
• Akcan Arikan A, Williams EA, Graf JM, et al. Resuscitation bundle in pediatric shock decreases acute kidney injury and improves outcomes. J Pediatr. 2015;167:1301–1305.e1.
   PubMed Web of Science ®Google Scholar
• Wallisch JS, Pang D, Carcillo JA, et al. Implementation of guidelines to treat pediatric sepsis: cookbook medicine or the force awakens! Pediatr Crit Care Med. 2016;17:884–885.
   PubMed Web of Science ®Google Scholar
• Chu C-M, Kao K-C, Huang S-H, et al. Diagnostic value of apoptosis biomarkers in severe sepsis – a pilot study. Cell Mol Biol Noisy–Gd Fr. 2016;62:32–37.
   PubMed Web of Science ®Google Scholar
• Wong HR, Weiss SL, Giuliano JS, et al. Testing the prognostic accuracy of the updated pediatric sepsis biomarker risk model. Plos One. 2014;9:e86242.
   PubMed Web of Science ®Google Scholar
• Gotts JE, Matthay MA. Sepsis: pathophysiology and clinical management. BMJ. 2016;353:i1585.
   PubMed Web of Science ®Google Scholar
• Jensen J-U, Bouadma L. Why biomarkers failed in sepsis. Intensive Care Med. 2016;42:2049–2051.
   PubMed Web of Science ®Google Scholar
• Briassoulis G, Briassouli E, Fitrolaki D-M, et al. Heat shock protein 72 expressing stress in sepsis: unbridgeable gap between animal and human studies – a hypothetical “comparative” study. Biomed Res Int. 2014;2014:1–17.
   Web of Science ®Google Scholar
• Briassouli E, Briassoulis G. Glutamine randomized studies in early life: the unsolved riddle of experimental and clinical studies. Clin Dev Immunol. 2012;2012:1–17.
   Google Scholar
• Prkno A, Wacker C, Brunkhorst FM, et al. Procalcitonin-guided therapy in intensive care unit patients with severe sepsis and septic shock – a systematic review and meta-analysis. Crit Care. 2013;17:R291.
   PubMed Web of Science ®Google Scholar
• Jensen JU, Hein L, Lundgren B, et al. Procalcitonin-guided interventions against infections to increase early appropriate antibiotics and improve survival in the intensive care unit: a randomized trial. Crit Care Med. 2011;39:2048–2058.
   PubMed Web of Science ®Google Scholar
• de Jong E, van Oers JA, Beishuizen A, et al. Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial. Lancet Infect Dis. 2016;16:819–827.
   PubMed Web of Science ®Google Scholar
• Briassoulis G, Ilia S. Vitamin D deficiency in sepsis: “Body Humors” imbalance or sepsis “epiphenomenon”? Crit Care Med. 2017;45:376–377.
   PubMed Web of Science ®Google Scholar
• Briassoulis G, Venkataraman S, Thompson A. Cytokines and metabolic patterns in pediatric patients with critical illness. Clin Dev Immunol. 2010;2010:1–11.
   Google Scholar
• Vardas K, Apostolou K, Briassouli E, et al. Early response roles for prolactin cortisol and circulating and cellular levels of heat shock proteins 72 and 90α in severe sepsis and SIRS. Biomed Res Int. 2014;2014:1–8.
   Web of Science ®Google Scholar
• Fitrolaki M-D, Dimitriou H, Venihaki M, et al. Increased extracellular heat shock protein 90α in severe sepsis and SIRS associated with multiple organ failure and related to acute inflammatory-metabolic stress response in children. Medicine (Baltimore). 2016;95:e4651.
   PubMed Web of Science ®Google Scholar
• Papadopoulos P, Pistiki A, Theodorakopoulou M, et al. Immunoparalysis: clinical and immunological associations in SIRS and severe sepsis patients. Cytokine. 2017;92:83–92.
   PubMed Web of Science ®Google Scholar
• Fitrolaki D-M, Dimitriou H, Kalmanti M, et al. CD64-neutrophil expression and stress metabolic patterns in early sepsis and severe traumatic brain injury in children. BMC Pediatr. 2013;13:31.
   PubMed Web of Science ®Google Scholar
• Briassouli E, Tzanoudaki M, Goukos D, et al. Glutamine may repress the weak LPS and enhance the strong heat shock induction of monocyte and lymphocyte HSP72 proteins but may not modulate the HSP72 mRNA in patients with sepsis or trauma. Biomed Res Int. 2015;2015:1–15.
   Web of Science ®Google Scholar
• Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315:801–810.
   PubMed Web of Science ®Google Scholar
• Rhodes A, Evans LE, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med. 2017;43(3):304–377.
   PubMed Web of Science ®Google Scholar
• Lamontagne F, Harrison DA, Rowan KM. qSOFA for identifying sepsis among patients with infection. JAMA. 2017;317:267–268.
   PubMed Web of Science ®Google Scholar
• Freund Y, Lemachatti N, Krastinova E, et al. Prognostic accuracy of sepsis-3 criteria for in-hospital mortality among patients with suspected infection presenting to the emergency department. JAMA. 2017;317:301–308.
   PubMed Web of Science ®Google Scholar
• Raith EP, Udy AA, Bailey M, et al. Prognostic accuracy of the SOFA score, SIRS criteria, and qSOFA score for in-hospital mortality among adults with suspected infection admitted to the intensive care unit. JAMA. 2017;317:290–300.
   PubMed Web of Science ®Google Scholar
• Mouncey PR, Osborn TM, Power GS, et al. Trial of early, goal-directed resuscitation for septic shock. N Engl J Med. 2015;372:1301–1311.
   PubMed Web of Science ®Google Scholar
• Rhodes A, Phillips G, Beale R, et al. The surviving sepsis campaign bundles and outcome: results from the International Multicentre Prevalence Study on Sepsis (the IMPreSS study). Intensive Care Med. 2015;41:1620–1628.
   PubMed Web of Science ®Google Scholar
• Howell MD, Davis AM. Management of sepsis and septic shock. JAMA. 2017;317:847.
   Web of Science ®Google Scholar
• Morin L, Ray S, Wilson C, et al. Refractory septic shock in children: a European Society of Paediatric and Neonatal Intensive Care definition. Intensive Care Med. 2016;42:1948–1957.
   PubMed Web of Science ®Google Scholar
• Ranjit S, Aram G, Kissoon N, et al. Multimodal monitoring for hemodynamic categorization and management of pediatric septic shock: a pilot observational study*. Pediatr Crit Care Med. 2014;15:e17–e26.
   Google Scholar
• Sankar J, Sankar MJ, Suresh CP, et al. Early goal-directed therapy in pediatric septic shock: comparison of outcomes “with” and “without” intermittent superior venacaval oxygen saturation monitoring: a prospective cohort study*. Pediatr Crit Care Med. 2014;15:e157–e167.
   Google Scholar
• Ventura AMC, Shieh HH, Bousso A, et al. Double-blind prospective randomized controlled trial of dopamine versus epinephrine as first-line vasoactive drugs in pediatric septic shock. Crit Care Med. 2015;43:2292–2302.
   PubMed Web of Science ®Google Scholar
• Masarwa R, Paret G, Perlman A, et al. Role of vasopressin and terlipressin in refractory shock compared to conventional therapy in the neonatal and pediatric population: a systematic review, meta-analysis, and trial sequential analysis. Crit Care. 2017;21:1.
   PubMed Web of Science ®Google Scholar
• de Simone N, Racsa L, Bevan S, et al. Therapeutic plasma exchange in the management of sepsis and multiple organ dysfunction syndrome: a report of three cases. J Clin Apher. 2014;29:127–131.
   PubMed Web of Science ®Google Scholar
• Vardas K, Ilia S, Sertedaki A, et al. Increased glucocorticoid receptor expression in sepsis is related to heat shock proteins, cytokines, and cortisol and is associated with increased mortality. Intensive Care Med Exp. 2017;5:10.
   PubMedGoogle Scholar
• Singer M. The role of mitochondrial dysfunction in sepsis-induced multi-organ failure. Virulence. 2014;5:66–72.
   PubMed Web of Science ®Google Scholar